# Structural basis for higher-order DNA binding by a bacterial transcriptional regulator

**Authors:** Frederik Oskar Graversgaard Henriksen, Lan Bich Van, Ditlev Egeskov Brodersen, Ragnhild Bager Skjerning, Danielle A. Garsin, Kai Papenfort, Danielle A. Garsin, Kai Papenfort, Danielle A. Garsin, Kai Papenfort, Danielle A. Garsin, Kai Papenfort

PMC · DOI: 10.1371/journal.pgen.1011749 · 2025-06-27

## TL;DR

This study reveals how a bacterial toxin-antitoxin system regulates its own gene expression through dynamic protein-DNA interactions and structural asymmetry.

## Contribution

The paper provides a structural and mechanistic model of transcriptional autoregulation involving a unique 4:2 stoichiometric complex and concentration-dependent DNA binding.

## Key findings

- The Xre-RES complex binds DNA in a 1:1 molar ratio with an asymmetric interaction.
- The complex can transition between DNA-binding and non-binding forms depending on antitoxin concentration.
- Structural analysis reveals a secondary DNA binding site and a dynamic autoregulation mechanism.

## Abstract

Transcriptional regulation by binding of transcription factors to palindromic sequences in promoter regions is a fundamental process in bacteria. Some transcription factors have multiple dimeric DNA-binding domains, in principle enabling interaction with higher-order DNA structures; however, mechanistic and structural insights into this phenomenon remain limited. The Pseudomonas putida toxin-antitoxin (TA) system Xre-RES has an unusual 4:2 stoichiometry including two potential DNA-binding sites, compatible with a complex mechanism of transcriptional autoregulation. Here, we show that the Xre-RES complex interacts specifically with a palindromic DNA repeat in the promoter in a 1:1 molar ratio, leading to transcriptional repression. We determine the 2.7 Å crystal structure of the protein-DNA complex, revealing an unexpected asymmetry in the interaction and suggesting the presence of a secondary binding site, which is supported by structural prediction of the binding to the intact promoter region. Additionally, we show that the antitoxin can be partially dislodged from the Xre-RES complex, resulting in Xre monomers and a 2:2 Xre-RES complex, neither of which repress transcription. These findings highlight a dynamic, concentration-dependent model of transcriptional autoregulation, in which the Xre-RES complex transitions between a non-binding (2:2) and a DNA-binding (4:2) form.

Bacteria regulate their gene expression to respond to environmental stress, to evade antibiotics, and to maintain population stability. In this study, we investigate how the xre-res toxin-antitoxin system from Pseudomonas putida controls its own expression. Using a combination of microbiology, structural biology, biophysical assays, and computational modelling, we discover how the Xre-RES protein complex represses its own transcription through direct binding to a specific DNA element in the promoter region. We show structurally that the Xre-RES complex adopts a unique 4:2 stoichiometry and binds DNA in an unusual asymmetrical manner. Moreover, the complex was found to shift between two different forms: one that binds DNA and represses transcription, and one that does not. We further demonstrate that this shift is dynamic and depends on the relative concentration of Xre antitoxin. Our findings provide new insight into how bacteria fine-tune gene expression and offers a model of transcriptional control based on protein stoichiometry and structural asymmetry.

## Linked entities

- **Proteins:** xre (phage PBSX transcriptional regulator), Res (Resurrector)
- **Species:** Pseudomonas putida (taxon 303)

## Full-text entities

- **Genes:** NR1I2 (nuclear receptor subfamily 1 group I member 2) [NCBI Gene 8856] {aka BXR, ONR1, PAR, PAR1, PAR2, PARq}, RES [NCBI Gene 18155454], Cro [NCBI Gene 2703467]
- **Diseases:** cystic fibrosis (MESH:D003550), P. aeruginosa infections (MESH:D011552)
- **Chemicals:** PEG 8000 (MESH:C000595216), 00196R1 (-), Ara (MESH:D016718), IPTG (MESH:D007544), kanamycin (MESH:D007612), nitrogen (MESH:D009584), PMSF (MESH:D010664), NaCl (MESH:D012965), chloramphenicol (MESH:D002701), hydrogen (MESH:D006859), arabinose (MESH:D001089), KOH (MESH:C029943), imidazole (MESH:C029899), MgCl2 (MESH:D015636), water (MESH:D014867), sucrose (MESH:D013395), glucose (MESH:D005947), glycerol (MESH:D005990), HEPES (MESH:D006531), KCl (MESH:D011189), AmS (MESH:D000645), Casamino acids (MESH:C017721), NAD+ (MESH:D009243)
- **Species:** Pseudomonas aeruginosa (species) [taxon 287], Sinorhizobium meliloti (species) [taxon 382], Homo sapiens (human, species) [taxon 9606], Vibrio parahaemolyticus (species) [taxon 670], Escherichia coli (E. coli, species) [taxon 562], Pseudomonas putida (species) [taxon 303], Photorhabdus luminescens (species) [taxon 29488], Pseudomonas putida S12 (strain) [taxon 1215087], Lambdavirus lambda (species) [taxon 10710]
- **Mutations:** S72A, Arg67, S65A, Thr68, W from residues 1-149, R67A, V68L
- **Cell lines:** S2 — Drosophila melanogaster (Fruit fly), Spontaneously immortalized cell line (CVCL_Z232), E. coli MG1655 — Homo sapiens (Human), Maple syrup urine disease, Transformed cell line (CVCL_D514), E. coli BL21(DE3) — Mus musculus (Mouse), Hybridoma (CVCL_B7HM), pET-29b — Homo sapiens (Human), Amyotrophic lateral sclerosis 1, Induced pluripotent stem cell (CVCL_9000)

## Figures

9 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12204516/full.md

---
Source: https://tomesphere.com/paper/PMC12204516